These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 19852927
1. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity. Zhang T, Hashizume T, Kurita-Ochiai T, Yamamoto M. Biochem Biophys Res Commun; 2009 Dec 18; 390(3):937-41. PubMed ID: 19852927 [Abstract] [Full Text] [Related]
2. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis. Maeba S, Otake S, Namikoshi J, Shibata Y, Hayakawa M, Abiko Y, Yamamoto M. Vaccine; 2005 Mar 31; 23(19):2513-21. PubMed ID: 15752838 [Abstract] [Full Text] [Related]
3. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses. Koizumi Y, Kurita-Ochiai T, Yamamoto M. Oral Microbiol Immunol; 2008 Apr 31; 23(2):131-8. PubMed ID: 18279181 [Abstract] [Full Text] [Related]
4. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity. Liu C, Hashizume T, Kurita-Ochiai T, Fujihashi K, Yamamoto M. Mol Oral Microbiol; 2010 Jun 31; 25(3):178-89. PubMed ID: 20502628 [Abstract] [Full Text] [Related]
5. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity. Yuzawa S, Kurita-Ochiai T, Hashizume T, Kobayashi R, Abiko Y, Yamamoto M. FEMS Immunol Med Microbiol; 2012 Mar 31; 64(2):265-72. PubMed ID: 22066647 [Abstract] [Full Text] [Related]
6. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice. Cai Y, Kurita-Ochiai T, Kobayashi R, Hashizume T, Yamamoto M. J Oral Sci; 2013 Mar 31; 55(2):107-14. PubMed ID: 23748449 [Abstract] [Full Text] [Related]
7. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Momoi F, Hashizume T, Kurita-Ochiai T, Yuki Y, Kiyono H, Yamamoto M. Infect Immun; 2008 Jun 31; 76(6):2777-84. PubMed ID: 18411288 [Abstract] [Full Text] [Related]
8. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. Takahashi Y, Kumada H, Hamada N, Haishima Y, Ozono S, Isaka M, Yasuda Y, Tochikubo K, Umemoto T. Oral Microbiol Immunol; 2007 Dec 31; 22(6):374-80. PubMed ID: 17949339 [Abstract] [Full Text] [Related]
9. The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats. Hamada N, Watanabe K, Tahara T, Nakazawa K, Ishida I, Shibata Y, Kobayashi T, Yoshie H, Abiko Y, Umemoto T. J Periodontol; 2007 May 31; 78(5):933-9. PubMed ID: 17470029 [Abstract] [Full Text] [Related]
10. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis. Namikoshi J, Otake S, Maeba S, Hayakawa M, Abiko Y, Yamamoto M. Vaccine; 2003 Dec 12; 22(2):250-6. PubMed ID: 14615153 [Abstract] [Full Text] [Related]
11. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein]. Zhang Y, Lu SQ, Zhang YZ, Zhao BX, Xu JG. Zhonghua Yi Xue Za Zhi; 2004 Jan 02; 84(1):58-62. PubMed ID: 14990161 [Abstract] [Full Text] [Related]
12. Nasal immunization with a fusion protein consisting of the hemagglutinin A antigenic region and the maltose-binding protein elicits CD11c(+) CD8(+) dendritic cells for induced long-term protective immunity. Du Y, Hashizume T, Kurita-Ochiai T, Yuzawa S, Abiko Y, Yamamoto M. Infect Immun; 2011 Feb 02; 79(2):895-904. PubMed ID: 21115722 [Abstract] [Full Text] [Related]
15. Association of the FcγRIIB-nt645+25A/G polymorphism with the expression level of the FcγRIIb receptor, the antibody response to Porphyromonas gingivalis and the severity of periodontitis. Sugita N, Iwanaga R, Kobayashi T, Yoshie H. J Periodontal Res; 2012 Feb 02; 47(1):105-13. PubMed ID: 21906057 [Abstract] [Full Text] [Related]
17. Strain-dependent activation of the mouse immune response is correlated with Porphyromonas gingivalis-induced experimental periodontitis. Wilensky A, Polak D, Awawdi S, Halabi A, Shapira L, Houri-Haddad Y. J Clin Periodontol; 2009 Nov 02; 36(11):915-21. PubMed ID: 19735468 [Abstract] [Full Text] [Related]
18. Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection. Frazer LT, O'Brien-Simpson NM, Slakeski N, Walsh KA, Veith PD, Chen CG, Barr IG, Reynolds EC. Vaccine; 2006 Oct 30; 24(42-43):6542-54. PubMed ID: 16839648 [Abstract] [Full Text] [Related]
19. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of Porphyromonas gingivalis. Kataoka K, Kawabata S, Koyanagi K, Hashimoto Y, Miyake T, Fujihashi K. Front Immunol; 2021 Oct 30; 12():634923. PubMed ID: 33717178 [Abstract] [Full Text] [Related]